Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry.

Gopalan A, Leversha MA, Dudas ME, Maschino AC, Chang J, Al-Ahmadie HA, Chen YB, Tickoo SK, Reuter VE, Fine SW.

Histopathology. 2013 Aug;63(2):279-86. doi: 10.1111/his.12153. Epub 2013 May 23.

2.

The mutational landscape of adenoid cystic carcinoma.

Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, Zhang J, Dolgalev I, Huberman K, Heguy A, Viale A, Drobnjak M, Leversha MA, Rice CE, Singh B, Iyer NG, Leemans CR, Bloemena E, Ferris RL, Seethala RR, Gross BE, Liang Y, Sinha R, Peng L, Raphael BJ, Turcan S, Gong Y, Schultz N, Kim S, Chiosea S, Shah JP, Sander C, Lee W, Chan TA.

Nat Genet. 2013 Jul;45(7):791-8. doi: 10.1038/ng.2643. Epub 2013 May 19.

3.

Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.

Szerlip NJ, Pedraza A, Chakravarty D, Azim M, McGuire J, Fang Y, Ozawa T, Holland EC, Huse JT, Jhanwar S, Leversha MA, Mikkelsen T, Brennan CW.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3041-6. doi: 10.1073/pnas.1114033109. Epub 2012 Feb 8.

4.

TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate.

Danila DC, Anand A, Sung CC, Heller G, Leversha MA, Cao L, Lilja H, Molina A, Sawyers CL, Fleisher M, Scher HI.

Eur Urol. 2011 Nov;60(5):897-904. doi: 10.1016/j.eururo.2011.07.011. Epub 2011 Jul 14.

5.

TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features.

Fine SW, Gopalan A, Leversha MA, Al-Ahmadie HA, Tickoo SK, Zhou Q, Satagopan JM, Scardino PT, Gerald WL, Reuter VE.

Mod Pathol. 2010 Oct;23(10):1325-33. doi: 10.1038/modpathol.2010.120. Epub 2010 Jun 18.

6.

Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer.

Leversha MA, Han J, Asgari Z, Danila DC, Lin O, Gonzalez-Espinoza R, Anand A, Lilja H, Heller G, Fleisher M, Scher HI.

Clin Cancer Res. 2009 Mar 15;15(6):2091-7. doi: 10.1158/1078-0432.CCR-08-2036. Epub 2009 Mar 10.

7.

TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy.

Gopalan A, Leversha MA, Satagopan JM, Zhou Q, Al-Ahmadie HA, Fine SW, Eastham JA, Scardino PT, Scher HI, Tickoo SK, Reuter VE, Gerald WL.

Cancer Res. 2009 Feb 15;69(4):1400-6. doi: 10.1158/0008-5472.CAN-08-2467. Epub 2009 Feb 3.

8.

Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line.

Zhao Q, Caballero OL, Levy S, Stevenson BJ, Iseli C, de Souza SJ, Galante PA, Busam D, Leversha MA, Chadalavada K, Rogers YH, Venter JC, Simpson AJ, Strausberg RL.

Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1886-91. doi: 10.1073/pnas.0812945106. Epub 2009 Jan 30.

9.

DNA copy number analysis in gastrointestinal stromal tumors using gene expression microarrays.

Antonescu CR, Wu K, Xing GL, Cao M, Turpaz Y, Leversha MA, Hubbell E, Maki RG, Miyada CG, Pillai R.

Cancer Inform. 2008;6:59-75. Epub 2008 Mar 27.

10.

Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.

Shaffer DR, Leversha MA, Danila DC, Lin O, Gonzalez-Espinoza R, Gu B, Anand A, Smith K, Maslak P, Doyle GV, Terstappen LW, Lilja H, Heller G, Fleisher M, Scher HI.

Clin Cancer Res. 2007 Apr 1;13(7):2023-9.

11.

Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation.

Antonescu CR, Besmer P, Guo T, Arkun K, Hom G, Koryotowski B, Leversha MA, Jeffrey PD, Desantis D, Singer S, Brennan MF, Maki RG, DeMatteo RP.

Clin Cancer Res. 2005 Jun 1;11(11):4182-90.

12.

Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays.

Leversha MA, Fielding P, Watson S, Gosney JR, Field JK.

J Pathol. 2003 Aug;200(5):610-9.

PMID:
12898597
13.

Mapping of genomic clones by fluorescence in situ hybridization.

Leversha MA.

Methods Mol Biol. 2001;175:109-27. Review. No abstract available.

PMID:
11462829
14.

The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X.

Bentley DR, Deloukas P, Dunham A, French L, Gregory SG, Humphray SJ, Mungall AJ, Ross MT, Carter NP, Dunham I, Scott CE, Ashcroft KJ, Atkinson AL, Aubin K, Beare DM, Bethel G, Brady N, Brook JC, Burford DC, Burrill WD, Burrows C, Butler AP, Carder C, Catanese JJ, Clee CM, Clegg SM, Cobley V, Coffey AJ, Cole CG, Collins JE, Conquer JS, Cooper RA, Culley KM, Dawson E, Dearden FL, Durbin RM, de Jong PJ, Dhami PD, Earthrowl ME, Edwards CA, Evans RS, Gillson CJ, Ghori J, Green L, Gwilliam R, Halls KS, Hammond S, Harper GL, Heathcott RW, Holden JL, Holloway E, Hopkins BL, Howard PJ, Howell GR, Huckle EJ, Hughes J, Hunt PJ, Hunt SE, Izmajlowicz M, Jones CA, Joseph SS, Laird G, Langford CF, Lehvaslaiho MH, Leversha MA, McCann OT, McDonald LM, McDowall J, Maslen GL, Mistry D, Moschonas NK, Neocleous V, Pearson DM, Phillips KJ, Porter KM, Prathalingam SR, Ramsey YH, Ranby SA, Rice CM, Rogers J, Rogers LJ, Sarafidou T, Scott DJ, Sharp GJ, Shaw-Smith CJ, Smink LJ, Soderlund C, Sotheran EC, Steingruber HE, Sulston JE, Taylor A, Taylor RG, Thorpe AA, Tinsley E, Warry GL, Whittaker A, Whittaker P, Williams SH, Wilmer TE, Wooster R, Wright CL.

Nature. 2001 Feb 15;409(6822):942-3.

PMID:
11237015
15.

A systematic, high-resolution linkage of the cytogenetic and physical maps of the human genome.

Kirsch IR, Green ED, Yonescu R, Strausberg R, Carter N, Bentley D, Leversha MA, Dunham I, Braden VV, Hilgenfeld E, Schuler G, Lash AE, Shen GL, Martelli M, Kuehl WM, Klausner RD, Ried T.

Nat Genet. 2000 Apr;24(4):339-40. No abstract available.

PMID:
10742091
16.

A molecular cytogenetic clone resource for chromosome 22.

Leversha MA, Dunham I, Carter NP.

Chromosome Res. 1999;7(7):571-3. No abstract available.

PMID:
10598573
17.

High-resolution landmark framework for the sequence-ready mapping of Xq23-q26.1.

Steingruber HE, Dunham A, Coffey AJ, Clegg SM, Howell GR, Maslen GL, Scott CE, Gwilliam R, Hunt PJ, Sotheran EC, Huckle EJ, Hunt SE, Dhami P, Soderlund C, Leversha MA, Bentley DR, Ross MT.

Genome Res. 1999 Aug;9(8):751-62.

18.

Assignment of the human stress-activated protein kinase-3 gene (SAPK3) to chromosome 22q13.3 by fluorescence in situ hybridization.

Goedert M, Hasegawa J, Craxton M, Leversha MA, Clegg S.

Genomics. 1997 May 1;41(3):501-2. No abstract available.

PMID:
9169156
19.

From long range mapping to sequence-ready contigs on human chromosome 6.

Mungall AJ, Humphray SJ, Ranby SA, Edwards CA, Heathcott RW, Clee CM, Holloway E, Peck AI, Harrison P, Green LD, Butler AP, Langford CF, William RG, Huckle EJ, Baron L, Smith A, Leversha MA, Ramsey YH, Clegg SM, Rice CM, Maslen GL, Hunt SE, Scott CE, Soderlund CA, Dunham I, et al.

DNA Seq. 1997;8(3):151-4.

PMID:
10668960
20.

A member of the MAP kinase phosphatase gene family in mouse containing a complex trinucleotide repeat in the coding region.

Theodosiou AM, Rodrigues NR, Nesbit MA, Ambrose HJ, Paterson H, McLellan-Arnold E, Boyd Y, Leversha MA, Owen N, Blake DJ, Ashworth A, Davies KE.

Hum Mol Genet. 1996 May;5(5):675-84.

PMID:
8733137
21.

A high-density YAC contig map of human chromosome 22.

Collins JE, Cole CG, Smink LJ, Garrett CL, Leversha MA, Soderlund CA, Maslen GL, Everett LA, Rice KM, Coffey AJ, et al.

Nature. 1995 Sep 28;377(6547 Suppl):367-79.

22.

Physical analysis of the tuberous sclerosis region in 9q34.

Zhou CY, Wu KY, Leversha MA, Furlong RA, Ferguson-Smith MA, Affara NA.

Genomics. 1995 Jan 1;25(1):304-8.

PMID:
7774937
23.

Localization of the gene (LAMA4) to chromosome 6q21 and isolation of a partial cDNA encoding a variant laminin A chain.

Richards AJ, al-Imara L, Carter NP, Lloyd JC, Leversha MA, Pope FM.

Genomics. 1994 Jul 1;22(1):237-9.

PMID:
7959779
24.

Coincidence painting: a rapid method for cloning region specific DNA sequences.

Bailey DM, Carter NP, de Vos D, Leversha MA, Perryman MT, Ferguson-Smith MA.

Nucleic Acids Res. 1993 Nov 11;21(22):5117-23. Erratum in: Nucleic Acids Res 1994 Feb 25;22(4):700.

25.

Physical mapping of chromosome 3p25-p26 by fluorescence in situ hybridisation (FISH).

Phipps ME, Maher ER, Affara NA, Latif F, Leversha MA, Ferguson-Smith ME, Nakamura Y, Lerman M, Zbar B, Ferguson-Smith MA.

Hum Genet. 1993 Aug;92(1):18-22.

PMID:
8365722
26.

Structure and expression analysis of a member of the human glutamate dehydrogenase (GLUD) gene family mapped to chromosome 10p11.2.

Tzimagiorgis G, Leversha MA, Chroniary K, Goulielmos G, Sargent CA, Ferguson-Smith M, Moschonas NK.

Hum Genet. 1993 Jun;91(5):433-8.

PMID:
8314555
27.

FISH and the technicolour revolution. Molecular cytogenetics and its application in chromosome analysis today.

Leversha MA.

Med J Aust. 1993 Apr 19;158(8):545-51. Review. No abstract available.

PMID:
8487720
28.

Duplicated KOX zinc finger gene clusters flank the centromere of human chromosome 10: evidence for a pericentric inversion during primate evolution.

Tunnacliffe A, Liu L, Moore JK, Leversha MA, Jackson MS, Papi L, Ferguson-Smith MA, Thiesen HJ, Ponder BA.

Nucleic Acids Res. 1993 Mar 25;21(6):1409-17.

29.

Multiple self-healing squamous epitheliomata (ESS1) mapped to chromosome 9q22-q31 in families with common ancestry.

Goudie DR, Yuille MA, Leversha MA, Furlong RA, Carter NP, Lush MJ, Affara NA, Ferguson-Smith MA.

Nat Genet. 1993 Feb;3(2):165-9.

PMID:
8499949
30.

Reverse chromosome painting: a method for the rapid analysis of aberrant chromosomes in clinical cytogenetics.

Carter NP, Ferguson-Smith MA, Perryman MT, Telenius H, Pelmear AH, Leversha MA, Glancy MT, Wood SL, Cook K, Dyson HM, et al.

J Med Genet. 1992 May;29(5):299-307.

31.

A dinucleotide repeat polymorphism at the D9S127 locus.

Lyall JE, Furlong RA, Yuille MA, Goudie DR, Leversha MA, Affara NA, Ferguson-Smith MA.

Nucleic Acids Res. 1992 Feb 25;20(4):925. No abstract available.

32.

A dinucleotide repeat polymorphism at the D9S109 locus.

Furlong RA, Lyall JE, Goudie DR, Leversha MA, Affara NA, Ferguson-Smith MA.

Nucleic Acids Res. 1992 Feb 25;20(4):925. No abstract available.

33.

Mapping of two human homologs of a Drosophila heterochromatin protein gene to the X chromosome.

Reik W, Leversha MA, Waterfield NR, Singh PB.

Mamm Genome. 1992;3(11):650-2. No abstract available.

PMID:
1450515
34.

Five cases demonstrating the distinctive behavioural features of chromosome deletion 17(p11.2 p11.2) (Smith-Magenis syndrome).

Colley AF, Leversha MA, Voullaire LE, Rogers JG.

J Paediatr Child Health. 1990 Feb;26(1):17-21.

PMID:
2331413
35.

Chromosome deletion at 11q23 in an abnormal child from a family with inherited fragility at 11q23.

Voullaire LE, Webb GC, Leversha MA.

Hum Genet. 1987 Jun;76(2):202-4.

PMID:
3610150
36.

49,XXYY, +18 in a liveborn male.

Webb GC, Krumins EJ, Leversha MA, Ford GW.

J Med Genet. 1984 Jun;21(3):232. No abstract available.

37.

Chromosome banding required for studies on X-linked mental retardation.

Leversha MA, Webb GC, Pavey SM.

Lancet. 1981 Jan 3;1(8210):49. No abstract available.

PMID:
6109088
38.

Chromosomes in miscarriage.

Leversha MA, Susman MR.

Am J Obstet Gynecol. 1978 Jan 15;130(2):245-6. No abstract available.

PMID:
619672

Supplemental Content

Loading ...
Support Center